Davide Maffei
Overview
Explore the profile of Davide Maffei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
223
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Woernle A, Dickinson L, Lelie S, Pendse D, Heffernan Ho D, Ramachandran N, et al.
Eur J Radiol
. 2023 Apr;
162:110796.
PMID: 37003197
Purpose: To investigate the utility of a prostate magnetic resonance imaging (MRI) second read using a semi-automated software program in the one-stop clinic, where patients undergo multiparametric MRI, review and...
12.
Maffei D, Fasulo V, Avolio P, Saitta C, Paciotti M, De Carne F, et al.
Prostate
. 2023 Mar;
83(9):886-895.
PMID: 36960788
Background: Active surveillance (AS) represents a standard of care of low-risk prostate cancer (PCa). However, the identification and monitoring of AS candidates remains challenging. Microultrasound (microUS) is a novel high-resolution...
13.
Avolio P, Lughezzani G, Fasulo V, Maffei D, Sanchez-Salas R, Paciotti M, et al.
Eur Urol Open Sci
. 2023 Jan;
47:73-79.
PMID: 36601049
Background: Multiparametric magnetic resonance imaging (mpMRI) is an invaluable diagnostic tool in the decision-making for prostate biopsies (PBx). However, a non-negligible proportion of patients with negative MRI (nMRI) may still...
14.
Mehdiyev T, Maffei D, Muller V, Mair W, Zimmermann R, Baur E
Plast Reconstr Surg Glob Open
. 2022 Oct;
10(10):e4604.
PMID: 36299815
Methods: In this retrospective analysis, we compare treatment outcomes in 35 patients, of whom 22 were treated with PNF and 13 with CCH injection. Results: The mean outcome in contracture...
15.
Maffei D, Giganti F, Moore C
Urol Oncol
. 2022 Jul;
41(2):88-91.
PMID: 35871993
Prostate cancer is the commonest cancer in men in Europe and many countries worldwide, and the second commonest cause of cancer-related death. A screening programme to detect clinically relevant prostate...
16.
Frego N, Paciotti M, Buffi N, Maffei D, Contieri R, Avolio P, et al.
Front Surg
. 2022 Mar;
9:829515.
PMID: 35284478
Introduction: To externally validate and directly compare the performance of the Briganti 2012 and Briganti 2019 nomograms as predictors of lymph node invasion (LNI) in a cohort of patients treated...
17.
Fasulo V, Buffi N, Regis F, Paciotti M, Persico F, Maffei D, et al.
World J Urol
. 2022 Jan;
40(2):435-442.
PMID: 35001161
Purpose: We aim to evaluate the accuracy of micro-ultrasound (microUS) in predicting extraprostatic extension (EPE) of Prostate Cancer (PCa) prior to surgery. Methods: Patients with biopsy-proven PCa scheduled for robot-assisted...
18.
Avolio P, Lughezzani G, Paciotti M, Maffei D, Uleri A, Frego N, et al.
Urol Oncol
. 2021 Jun;
39(12):832.e1-832.e7.
PMID: 34183255
Introduction: Magnetic Resonance Imaging (MRI) has emerged as the most accurate diagnostic tool, showing a high sensitivity in the diagnosis of clinically significant prostate cancer (csCaP). However only a minority...
19.
Cieri M, Contieri R, De Carlo C, Lughezzani G, Maffei D, Colombo P
Res Rep Urol
. 2021 Feb;
13:41-44.
PMID: 33537246
Signs and symptoms associated with testicular and paratesticular structures should not be underestimated because they may hide diseases requiring immediate evaluation and treatment, such as germline tumors or sarcomas, with...
20.
Zanoni M, Grizzi F, Maffei D, Vota P, Frego N, Toia G, et al.
World J Urol
. 2020 Oct;
39(7):2475-2481.
PMID: 33112984
Background And Purpose: Urinary continence (UC) represents the main non-oncological goal in patients undergoing robotic-assisted radical prostatectomy (RARP). To evaluate the efficacy in early UC achievement, we described a new...